Better Therapy Brighter Outlook

About Lumosa

+
More LUMOSA
News Center

LT3001 Compound Patent Approved in Korea and Europe

Detail

First Dosing of Lumosa's LT3001 in China

Detail

Naldebain Approved by Singapore HSA

Detail
+
More News
reSEARCH & DEVELOPMENT
Pipeline NameDisease Treatment
Compound SelectionPre-clinicalPhase 1Phase 2Phase 3NDALaunch
Pre-clinical
+
More Pipeline
+Close